Lawrence Peter J, Parkinson Monika, Jasper Bec, Creswell Cathy, Halligan Sarah L
School of Psychology, University of Southampton, Southampton, UK.
School of Psychology and Clinical Language Sciences, University of Reading, Reading, UK.
Lancet Psychiatry. 2021 Oct;8(10):909-918. doi: 10.1016/S2215-0366(20)30315-1.
Guidance is scarce on whether and how to involve parents in treatment for anxiety and depressive disorders in children and young people. We did a scoping review of randomised controlled trials of psychological interventions for anxiety and depressive disorders in children and young people, in which parents were involved in treatment, to identify how parents and carers have been involved in such treatments, how this relates to both child and broader outcomes, and where research should focus. We identified 73 trials: 62 focused on anxiety and 11 on depressive disorders. How parents were involved in treatments varied greatly, with at least 13 different combinations of ways of involving parents in the anxiety trials and seven different combinations in the depression trials. Including parents in treatment did not impair children's and young people's outcomes, but the wide variability in how they were involved prevents clarity about why some trials favoured parent involvement and others did not. Studies must consider the long-term and wider benefits beyond children's and young people's mental health, such as enhanced engagement, family wellbeing, and economic gains.
关于是否以及如何让父母参与儿童和青少年焦虑症及抑郁症的治疗,相关指导意见很少。我们对儿童和青少年焦虑症及抑郁症心理干预的随机对照试验进行了一项范围综述,这些试验中父母参与了治疗,以确定父母和照顾者是如何参与此类治疗的,这与儿童及更广泛的结果有何关联,以及研究应聚焦于何处。我们确定了73项试验:62项聚焦于焦虑症,11项聚焦于抑郁症。父母参与治疗的方式差异很大,在焦虑症试验中,父母参与治疗的方式至少有13种不同组合,在抑郁症试验中有7种不同组合。让父母参与治疗并未损害儿童和青少年的治疗效果,但他们参与方式的广泛差异使得难以明确为何有些试验支持父母参与而有些则不支持。研究必须考虑儿童和青少年心理健康之外的长期和更广泛的益处,如更高的参与度、家庭幸福感和经济收益。